Overview
Immune tolerance therapy (ITT) involves infusing clotting factor concentrate in scheduled doses to train the body to tolerate the factor. The goal of ITT is to eradicate the inhibitor.
What does it involve?… read more
Overview
Hemlibra is approved by the Food and Drug Administration (FDA) as routine prophylaxis in children and adults with hemophilia A and factor VIII inhibitors. The technical name of Hemlibra is Emicizumab-kxwh.… read more